Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V
Open Access
- 18 August 2020
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-14
Abstract
Mutated receptor tyrosine kinases (MT-RTKs) such as internal tandem duplication of FMS-like tyrosine kinase 3 (FLT3 ITD) and a point mutation KIT D816V are driver mutations for acute myeloid leukemia (AML). Clathrin assembly lymphoid myeloid leukemia protein (CALM) regulates intracellular transport of RTKs, however, the precise role for MT-RTKs remains elusive. We here show that CALM knock down leads to severely impaired FLT3 ITD- or KIT D814V-dependent cell growth compared to marginal influence on wild-type FLT3- or KIT-mediated cell growth. An antipsychotic drug chlorpromazine (CPZ) suppresses the growth of primary AML samples, and human CD34+CD38- AML cells including AML initiating cells with MT-RTKs in vitro and in vivo. Mechanistically, CPZ reduces CALM protein at post transcriptional level and perturbs the intracellular localization of MT-RTKs, thereby blocking their signaling. Our study presents a therapeutic strategy for AML with MT-RTKs by altering the intracellular localization of MT-RTKs using CPZ.Keywords
This publication has 58 references indexed in Scilit:
- Potential use of Folate-appended Methyl-β-Cyclodextrin as an Anticancer AgentScientific Reports, 2013
- FLT3 inhibition: a moving and evolving target in acute myeloid leukaemiaLeukemia, 2012
- The Clathrin Assembly Protein PICALM Is Required for Erythroid Maturation and Transferrin Internalization in MicePLOS ONE, 2012
- The Molecular Basis for the Endocytosis of Small R-SNAREs by the Clathrin Adaptor CALMCell, 2011
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptorJournal of Cell Biology, 2010
- The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and PitfallsMolecular Therapy, 2010
- The role of CALM–AF10 gene fusion in acute leukemiaLeukemia, 2007
- The occurence of cancer in first admitted schizophrenic patientsSchizophrenia Research, 1994
- CHLORPROMAZINES AND CANCERThe Lancet, 1972